These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6323781)

  • 1. Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism.
    Mizuno K; Yamazaki M; Ikeda K; Yaginuma K; Hashimoto S; Fukuchi S
    Jpn Heart J; 1983 Nov; 24(6):917-24. PubMed ID: 6323781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of metoclopramide, a dopamine inhibitor, on aldosterone secretion in patients with primary aldosteronism].
    Mizuno K; Yaginuma K; Yamazaki M; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1982 Aug; 58(8):976-83. PubMed ID: 6292008
    [No Abstract]   [Full Text] [Related]  

  • 3. Differing effects of metoclopramide and adrenocorticotropin on plasma aldosterone levels in glucocorticoid-suppressible hyperaldosteronism and other forms of hyperaldosteronism.
    Ganguly A; Pratt JH; Weinberger MH; Grim CE; Fineberg NS
    J Clin Endocrinol Metab; 1983 Aug; 57(2):388-92. PubMed ID: 6306041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic modulation of aldosterone secretion: effect of sodium balance and postural changes.
    García-Robles R; Ruilope L; Mancheño E; Hurtado A; Alcázar JM; Varela C; de la Calle H; Rodicio JL; Sancho J
    Rev Esp Fisiol; 1984 Mar; 40(1):63-8. PubMed ID: 6087430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of metoclopramide on aldosterone and regulatory factors in man.
    Gilchrist NL; Espiner EA; Nicholls MG; Donald RA
    Clin Endocrinol (Oxf); 1984 Jul; 21(1):1-7. PubMed ID: 6086181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism.
    Witzgall H; Lorenz R; von Werder K; Weber PC
    Clin Sci (Lond); 1985 Mar; 68(3):291-9. PubMed ID: 3882312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of metoclopramide-induced prolactin on aldosterone secretion in normal subjects.
    Ogihara T; Matsumura S; Onishi T; Miyai K; Uozumi T
    Life Sci; 1977 Feb; 20(3):523-6. PubMed ID: 839976
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary aldosteronism: effects of inhibition of ACTH and potassium administration on plasma aldosterone concentration.
    Ganguly A; Luetscher JA; Weinberger MH
    Clin Exp Hypertens A; 1982; 4(9-10):1695-714. PubMed ID: 6291813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic regulation of aldosterone secretion: assessment in different subtypes of primary aldosteronism and in essential hypertension.
    Veglio F; Pinna G; Rabbia F; Panarelli M; Bisbocci D; Melchio R; Chiandussi L
    J Int Med Res; 1991; 19(1):44-9. PubMed ID: 1850365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of aldosterone secretion in primary aldosteronism.
    Vetter H; Vetter W
    Horm Metab Res; 1975 Sep; 7(5):418-24. PubMed ID: 1183923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of naloxone on the adrenal cortex in primary aldosteronism.
    Fallo F; Boscaro M; Sonino N; Mantero F
    Am J Hypertens; 1988 Jul; 1(3 Pt 1):280-2. PubMed ID: 2839206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension.
    Kem DC; Weinberger MH; Higgins JR; Kramer NJ; Gomez-Sanchez C; Holland OB
    J Clin Endocrinol Metab; 1978 Apr; 46(4):552-60. PubMed ID: 225341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism.
    Kem DC; Weinberger MH; Gomez-Sanchez C; Kramer NJ; Lerman R; Furuyama S; Nugent CA
    J Clin Invest; 1973 Sep; 52(9):2272-7. PubMed ID: 4353776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of upright posture on the aldosterone responses to dopamine, metoclopramide, angiotensin II, and adrenocorticotropin.
    Malchoff CD; Hughes JM; Carey RM
    J Clin Endocrinol Metab; 1987 Jul; 65(1):203-7. PubMed ID: 3034955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of atrial natriuretic hormone on metoclopramide-induced stimulation of aldosterone.
    Shenker Y; Meranda D; Clinkingbeard C; Lawrence D; Koch D
    J Lab Clin Med; 1992 Aug; 120(2):297-304. PubMed ID: 1323636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of dexamethasone on the control of plasma aldosterone concentration in normal recumbent man.
    Weinberger MH; Kem DC; Gomez-Sanchez C; Kramer NJ; Martin BT; Nugent CA
    J Lab Clin Med; 1975 Jun; 85(6):957-67. PubMed ID: 166119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effects of metoclopramide and dopamine on aldosterone secretion in cultured adrenocortical adenoma cells and adjacent non-adenoma cells from patients with primary aldosteronism].
    Yanase T; Nawata H; Higuchi K; Kato K; Ibayashi H
    Nihon Naibunpi Gakkai Zasshi; 1985 Jun; 61(6):631-41. PubMed ID: 4054405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute dopaminergic inhibition of aldosterone secretion is independent of angiotensin II and adrenocorticotropin.
    Carey RM
    J Clin Endocrinol Metab; 1982 Feb; 54(2):463-9. PubMed ID: 6274907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of posture on the plasma concentrations of aldosterone in hypertension and primary hyperaldosteronism.
    Biglieri EG
    Nephron; 1979; 23(2-3):112-5. PubMed ID: 220544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.